ÂÜÀòÂÒÂ×

Kelly Qiao is an experienced investor and board member, currently involved in multiple companies such as Spectrumedics International, Grit Biotechnology, AlphaLife Sciences, ProfoundBio, Beijing Yuanxin Technology Co., Ltd., and others. Kelly also served as a Senior Principal at B Capital, and previously worked as Managing Director at Taikang Insurance Group Inc., specializing in PE investments. With a PhD in Biology from Tsinghua University, a Bachelor's degree in Chemistry from Tsinghua University, and an MBA in Finance from The Chinese University of Hong Kong, Kelly's educational background complements their successful career in investments and business management.